Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study

Trial Profile

Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 31 Jan 2019

At a glance

  • Drugs Aclerastide (Primary)
  • Indications Wounds
  • Focus Adverse reactions
  • Sponsors US Biotest Inc
  • Most Recent Events

    • 22 Jan 2019 Planned End Date changed from 1 Oct 2018 to 1 Feb 2019.
    • 22 Jan 2019 Status changed from recruiting to active, no longer recruiting.
    • 08 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top